logo

For the Inventor, By the Inventor

Palo Alto, CA, United States of America

Paul R Magruder

This inventor holds 10 USPTO granted patents. Top assignee: Alza Corporation. Active years: 1988-1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul R Magruder. Retrieved from https://idiyas.com/inventor/paul-r-magruder

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 10

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 9

Forward Citations = 448(Granted Patents)


Location History:

  • Palo Alto, CA (US) (1988 - 1990)
  • Mt. View, CA (US) (1990)

Company Filing History:

goldMedal10 out of 1,062 
 
Alza Corporation
 patents

Years Active: 1988-1990

Loading Chart...
10 patents (USPTO):Explore Patents
1. 4971790 - Dosage form for lessening irritation of mocusa (1990-11-20),
2. 4915954 - Dosage form for delivering a drug at two different rates (1990-04-10),
3. 4915953 - Dosage form for delivering acetaminophen or phenylpropanolamine (1990-04-10),
4. 4867969 - Hydrogel formulation for administering non-steroidal drugs (1989-09-19),
5. 4851229 - Composition comprising a therapeutic agent and a modulating agent (1989-07-25),
6. 4814181 - Dosage form comprising fast agent delivery followed by slow agent (1989-03-21),
7. 4777049 - Constant release system with pulsed release (1988-10-11),
8. 4751071 - Composition comprising salbutamol (1988-06-14),
9. 4747847 - System for delivering potassium chloride with enhanced bioacceptability (1988-05-31),
10. 4723957 - System for delivering drug with enhanced bioacceptability (1988-02-09),

Title: The Innovations of Paul R Magruder

Introduction

Paul R Magruder is a notable inventor based in Palo Alto, CA, with a significant contribution to the field of pharmaceuticals. He holds a total of 10 patents, showcasing his innovative approach to drug delivery systems. His work has had a profound impact on how medications are formulated and administered.

Latest Patents

Among his latest patents, one includes a dosage form for lessening irritation of mucosa. This invention comprises a composition of matter that includes a drug, a neutral hydrogel, and an ionic hydrogel. The composition can be administered from a delivery system to a biological receptor over time. Another notable patent is for a dosage form that delivers acetaminophen or phenylpropanolamine. This dosage form features a wall that surrounds a compartment with an exit means, allowing for the release of a fast-releasing lamina and a short-releasing lamina over two different periods of time.

Career Highlights

Paul R Magruder has made significant strides in his career, particularly through his work at Alza Corporation. His innovative contributions have not only advanced pharmaceutical technology but have also improved patient care through more effective drug delivery methods.

Collaborations

Throughout his career, Magruder has collaborated with esteemed colleagues such as Patrick S Wong and Felix T Theeuwes. These partnerships have fostered a creative environment that has led to groundbreaking advancements in the field.

Conclusion

Paul R Magruder's contributions to pharmaceutical innovations exemplify the importance of creativity and collaboration in advancing medical technology. His patents reflect a commitment to improving drug delivery systems, ultimately benefiting patients and healthcare providers alike.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…